이식형 BCI 디바이스 시장 규모는 예측 기간 동안 연평균 10.42%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.
이식형 BCI 디바이스에 대한 수요는 신경 질환 및 운동 장애의 유병률 증가, 청각 및 시각 장애를 경험하는 환자 수 증가에 의해 크게 견인되고 있습니다. 또한, 디지털 헬스 솔루션의 채택 확대는 환자 치료의 전망을 재구성하고 시장 성장을 더욱 촉진하고 있습니다. 이러한 상승세에 기여하는 주요 요인으로는 보다 진보된 BCI 기기 개발을 위한 연구개발 활동의 활성화와 주요 기업 간의 전략적 제휴 등이 있습니다. 이러한 시장 개척은 2025년부터 2032년까지의 예측 기간 동안 이식형 BCI 디바이스 시장을 촉진하는 데 매우 중요한 역할을 할 것으로 예상됩니다.
임베디드 BCI 장치 시장 역학:
신경질환 및 운동장애의 유병률 증가가 이식형 CI 기기 시장 성장을 가속할 전망입니다. 세계보건기구(WHO)가 2024년 4월에 제공한 데이터에 따르면, 2021년에는 전 세계적으로 약 1,540만 명이 척수 손상을 앓고 있습니다.
2022년 UK Research and Innovation이 제공한 데이터에 따르면, 전 세계적으로 매년 약 1,000만 명이 외상성 뇌손상의 영향을 받고 있습니다. 이식형 BCI 장치는 TBI 후 뇌 기능 평가에 중요한 역할을 하며, 뇌 손상 정도에 대한 중요한 통찰력을 제공하고 치료 의사결정을 유도합니다. 이러한 신경손상 발생률 증가는 이식형 BCI 장치에 대한 수요를 증가시켜 시장 성장을 가속하고 있습니다.
2024년 세계보건기구(WHO)의 최신 데이터에 따르면, 2023년 전 세계적으로 약 5,000만 명이 간질을 앓고 있으며, 매년 약 500만 명이 새롭게 간질 진단을 받고 있습니다. 간질은 전 세계적으로 가장 흔한 신경질환 중 하나입니다. 데이터에 따르면 2023년에는 5,500만 명 이상이 치매를 앓고 있으며, 그 중 60% 이상이 중저소득 국가에 거주하고 있습니다. 매년 평균 1,000만 명에 가까운 사람들이 새롭게 치매 진단을 받고 있습니다. 이식형 BCI는 뇌 활동을 모니터링하여 발작과 관련된 비정상적인 전기적 패턴을 감지할 수 있으며, 간질을 보다 효과적으로 관리하는 데 도움이 되는 실시간 데이터를 제공할 수 있습니다. 이러한 운동장애의 유병률 증가는 시장 성장을 가속할 것으로 예상됩니다.
2023년 3월 세계보건기구(WHO) 자료에 따르면, 유럽에서 1억 9,000만 명 이상이 난청을 앓고 있으며, 이 수치는 2050년까지 2억 3,000만 명을 넘어설 것으로 예상되고 있습니다. 3,000만 명을 넘어설 것으로 예상됩니다. 이식형 BCI 디바이스는 청력을 회복하고 청각 경험을 향상시키는 데 중요한 역할을 합니다. 난청 환자 수가 지속적으로 증가함에 따라 혁신적인 BCI 기기에 대한 수요가 확대되고 시장 확대가 더욱 가속화될 것으로 보입니다.
세계의 이식형 BCI(Brain Computer Interface) 디바이스 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법 및 규제 환경, 시장 규모 추이 및 예측, 각종 부문별/지역별/주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요, 주요 기업 개요 등의 정보를 정리하여 전해드립니다. 정리하여 전해드립니다.
Implanted Brain-Computer Interface (BCI) Devices Market by Product (Hardware and Software), Approach (Invasive BCI and Minimally invasive BCI), Application (Epilepsy, Brain Injury, Depression, Stroke, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the growing prevalence of neurological and movement disorders and increasing technological innovations in BCI devices
The implanted brain-computer interface (BCI) devices market is estimated to grow at a CAGR of 10.42% during the forecast period from 2025 to 2032. The demand for implanted brain-computer interface (BCI) devices is significantly driven by the increasing prevalence of neurological and movement disorders and a rising number of patients experiencing hearing and vision loss. Additionally, the growing adoption of digital health solutions is reshaping the landscape of patient care, further fueling market growth. Key factors contributing to this upward trend include increasing research and development activities and strategic collaborations among leading players to develop more advanced BCI devices. These developments are expected to play a pivotal role in propelling the implanted BCI devices market during the forecast period from 2025 to 2032.
Implanted Brain-Computer Interface (BCI) Devices Market Dynamics:
The rising prevalence of neurological and movement disorders is poised to drive market growth for implanted brain-computer interface (BCI) devices. The data provided by the World Health Organization (WHO) in April 2024, mentioned that approximately 15.4 million people were living with spinal cord injury in 2021 worldwide.
According to data provided by UK Research and Innovation in 2022, approximately 10 million people are affected by traumatic brain injury every year in the world. Implanted BCI devices play a crucial role in evaluating brain function after TBI, offering vital insights into the extent of brain damage and guiding treatment decisions. This increasing incidence of neurological disorders is creating a heightened demand for implanted BCI devices, thereby propelling market growth.
According to recent data from the World Health Organization (WHO) in 2024, approximately 50 million people worldwide were living with epilepsy in 2023, with around 5 million new diagnoses occurring each year, making epilepsy one of the most common neurological disorders globally. As per the same source in 2023, over 55 million people were living with dementia, with more than 60% of these individuals located in low- and middle-income countries. Each year, nearly 10 million new cases are diagnosed on average. Implanted BCIs can monitor brain activity to detect abnormal electrical patterns associated with seizures, providing real-time data that can help manage epilepsy more effectively. Such increasing prevalence of movement disorders is expected to foster the market growth.
The increasing prevalence of hearing and vision loss is anticipated to significantly drive market growth for implanted brain-computer interface (BCI) devices. According to data from the World Health Organization (WHO) in March 2023, over 190 million people in Europe were living with hearing loss, a figure expected to surpass 230 million by 2050. Implanted BCI devices play a crucial role in restoring hearing, providing individuals with improved auditory experiences. As the number of people affected by hearing loss continues to rise, the demand for these innovative BCI devices is set to grow, further propelling market expansion.
Key players increasingly focus on technological innovations to develop advanced implanted brain-computer interface (BCI) devices that integrate cutting-edge technologies. For instance, in November 2022 Blackrock Neurotech, a U.S. based company launched Neuralace(TM). This next-generation neural interface is engineered with diverse materials and patterns to connect with extensive areas of the brain's surface. Neuralace is designed to perform complex functions without relying on assistive technologies, offering groundbreaking solutions for vision and memory restoration, performance prediction, and the treatment of mental health disorders. Such innovative product developments not only enhance the capabilities of BCI devices but also significantly drive market growth.
However, the complications and safety concerns associated with implanted BCI devices and high cost of BCI devices, among others are some of the key constraints that may limit the growth of the implanted brain-computer interface (BCI) devices market.
Implanted Brain-Computer Interface (BCI) Devices Market Segment Analysis:
Implanted Brain-Computer Interface (BCI) Devices Market by Product (Hardware and Software), Approach (Invasive BCI and Minimally invasive BCI), Application (Epilepsy, Brain Injury, Depression, Stroke, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product segment of the implanted brain-computer interface (BCI) devices market, the hardware category is estimated to amass a significant revenue share in the implanted brain-computer interface (BCI) devices market in 2024. This trend can be attributed to the rising incidence of patients suffering from strokes and spinal cord injuries worldwide. According to data from the Centers for Disease Control and Prevention (CDC) published in May 2024, over 795,000 individuals in the United States experience a stroke each year. Implanted BCI hardware such as electrodes and sensors are primarily designed to detect brain signals and facilitate communication between the brain and external devices. These BCIs can significantly assist stroke patients in regaining control over their bodies and improving motor functions. The increasing prevalence of strokes and spinal cord injuries is driving segment growth and contributing to the overall expansion of the implanted brain-computer interface (BCI) devices market.
The growth of the brain-computer interface (BCI) segment can also be attributed to the various advantages offered by the hardware utilized in these devices. BCIs have diverse applications in rehabilitation settings, where they play a crucial role in post-stroke or injury recovery. By promoting neuroplasticity, these devices enable patients to regain motor functions through targeted exercises that are controlled by their thoughts. This capability not only accelerates recovery but also empowers patients by facilitating a more intuitive interaction with their rehabilitation process. As awareness of these benefits grows, the demand for advanced BCI solutions in clinical and therapeutic contexts is expected to expand, further driving market growth.
Moreover, increasing research and development activities aimed at developing innovative implantable BCI devices are significantly fueling market growth. A notable example is Synchron's completion of the COMMAND trial in September 2023, which focused on its brain-computer interface (BCI) devices that received Investigational Device Exemption (IDE) from the FDA. The primary objective of this study was to determine the safety of implanting the device within the blood vessels of the brain using neuro-interventional procedures. Such R&D activities by key players are driving the market growth.
North America is expected to dominate the overall implanted brain-computer interface (BCI) devices market:
North America is expected to account for the largest market share in the implanted brain-computer interface (BCI) devices market in 2024, out of all regions. This can be attributed to the rising prevalence of hearing loss and neurological disorders, alongside a growing geriatric population. Additionally, the increasing healthcare awareness and ongoing technological innovations led by key industry players are significantly driving market growth in North America.
The rising prevalence of neurological disorders is a key factor driving market growth in North America. As per data from the Centers for Disease Control and Prevention (CDC) in September 2023, approximately 6.7 million individuals aged 65 and older were living with Alzheimer's disease in 2023, a number projected to increase to 13.9 million by 2060 in the United States.
According to data from the Centers for Disease Control and Prevention (CDC) published in May 2024, approximately 3 million individuals in the United States were living with epilepsy in 2021. Implanted BCI devices provide innovative solutions for rehabilitation and assistive technologies tailored to the needs of these individuals. Consequently, the increasing prevalence of neurological conditions is driving demand for implanted BCI devices, thereby significantly contributing to market growth in the region.
The increasing geriatric population, which is more susceptible to neurological and motor impairments, is significantly driving market growth in the region. According to data from the Population Reference Bureau published in January 2024, there were approximately 58 million individuals aged 65 and older in the United States in 2022, a number projected to rise to 82 million by 2050. As the global demographic of elderly individuals expands, the demand for implanted BCI devices that address age-related cognitive and mobility decline is also on the rise, thereby propelling the market growth.
The increasing focus on product development and launch activities by key players is significantly fostering market growth. For instance, in May 2024, CorTec announced that the FDA approved an Investigational Device Exemption (IDE) application for its closed-loop brain-computer interface (BCI). This innovative device is designed to support novel stroke rehabilitation treatments by utilizing cortical stimulation to enhance neuroplasticity within the brain. Such product development activities by key players are driving market growth in North America.
Implanted Brain-Computer Interface (BCI) Devices Market Key Players:
Some of the key market players operating in the implanted brain-computer interface (BCI) devices market include NeuroPace, Inc., Blackrock Neurotech, Synchron, LivaNova, Inc., BrainGate, BrainCo, Inc., Cognixion, Inc., Brain Products GmbH, Compumedics Neuroscan, CorTec, Snap Inc., g.tec medical engineering GmbH, Bitbrain Technologies, Nexstem India Pvt. Ltd., Paradromics, CereGate, Precision Neuroscience, ONWARD Medical N.V., NeuroSky, NeuroXess, and others.
Recent Developmental Activities in the Implanted Brain-Computer Interface (BCI) Devices Market:
Key Takeaways from the Implanted Brain-Computer Interface (BCI) Devices Market Report Study
Target Audience who can be benefited from this Implanted Brain-Computer Interface (BCI) Devices Market Report Study
Frequently Asked Questions for the Implanted Brain-Computer Interface (BCI) Devices Market: